Vander-Bend to Acquire Omni in Bid to Expand US Reach

Vander-Bend Manufacturing, a portfolio company of Aterian Investment Partners, recently announced the acquisition of Omni Components Corporation, an ISO 9001 & 13485 registered company, adding highly complex medical consumables and instrumentation for spinal, cardiovascular, and tendon related applications to its toolbox. Omni is a precision manufacturer and service provider of tight tolerance medical products focused in these three areas and has capabilities including prototyping, CNC Swiss machining, vertical milling, turnkey solutions, and wire/RAM EDM.

As a highly strategic expansion for Vander-Bend, the acquisition will establish an additional manufacturing footprint in the Northeast and Southwest, complementing its existing presence in the West Coast, Midwest, and Southeast regions of the United States. "This strategic acquisition broadens Vander-Bend's customer base, capabilities, and strategically positions us near key medtech innovation hubs…” said Rich Rivard, chief commercial officer at Vander-Bend.

Currently, the company boasts six facilities representing ~550,000 sq ft of combined manufacturing space with a broad spectrum of manufacturing capabilities and flexibility. Additionally, Vander-Bend has >260 pieces of production and support equipment including numerically-controlled punches, brakes, mills, and lasers.

"The acquisition of Omni represents an important strategic milestone for Vander-Bend,” said Brandon Bethea, co-founder and partner at Aterian. “By adding Omni, as well as the company's talented team, Vander-Bend now prototypes and manufactures at scale critical disposable and instrumentation components for multiple world-class OEMs in a diverse set of exciting medtech end markets. We would like to congratulate Frank and his team for building a truly one-of-a-kind business. We couldn't be more enthusiastic about the opportunity to work alongside the talented Omni team as we move forward together."

The recent acquisition is the fourth announced by Vander-Bend in the years since Aterian partnered with them in 2018 and will add an additional two facilities to Vander-Bend’s roster.

"This partnership supports our track record of investing in complementary family/founder run businesses in a fragmented outsourced medical technology manufacturing landscape,” said Daniel Phan, managing director at Aterian. “We look forward on working on post-close initiatives across the combined company."